{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:18:09Z","timestamp":1774970289659,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12943-1","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:03:12Z","timestamp":1771952592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cascade of care for latent tuberculosis infection in Malaysia: a cohort analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Aslene Siu Tjing","family":"Yeoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Ihsani","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mugilan","family":"Ganason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swee Hung","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Wee Yao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsoo","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Hafsah Abdul","family":"Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmah","family":"Razali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheamini","family":"Sivasampu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Seah Keng","family":"Tok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"22","key":"12943_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372(22):2127\u201335.","journal-title":"N Engl J Med"},{"key":"12943_CR2","doi-asserted-by":"crossref","unstructured":"Cohen A, Mathiasen VD, Sch\u00f6n T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54(3).","DOI":"10.1183\/13993003.00655-2019"},{"key":"12943_CR3","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018."},{"issue":"2","key":"12943_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","volume":"99","author":"GW Comstock","year":"1974","unstructured":"Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131\u20138.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"12943_CR5","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2214-109X(16)30199-1","volume":"4","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health. 2016;4(11):e806\u201315.","journal-title":"Lancet Glob Health"},{"key":"12943_CR6","volume-title":"Implementing the end TB strategy: the essentials, 2022 update","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Implementing the end TB strategy: the essentials, 2022 update. Geneva: World Health Organization; 2022."},{"key":"12943_CR7","doi-asserted-by":"crossref","unstructured":"Mandalakas AM, Hesseling AC, Kay A, Du Preez K, Martinez L, Ronge L, et al. Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021;57(4).","DOI":"10.1183\/13993003.03028-2020"},{"issue":"2","key":"12943_CR8","first-page":"CD001363","volume":"1999","author":"MJ Smieja","year":"2000","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;1999(2):CD001363.","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"12943_CR9","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","volume":"364","author":"CR Horsburgh","year":"2011","unstructured":"Horsburgh CR, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011;364(15):1441\u20138.","journal-title":"N Engl J Med"},{"key":"12943_CR10","unstructured":"National strategic plan for tuberculosis control (2021\u20132030). Malaysia: Disease Control Division, Ministry of Health Malaysia; 2024."},{"key":"12943_CR11","volume-title":"Global tuberculosis report 2025","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization; 2025."},{"key":"12943_CR12","unstructured":"World Health Organization. Tuberculosis epidemiological profile: Malaysia. https:\/\/data.who.int\/dashboards\/tuberculosis?m49=458. Assessed 16 Jan 2025."},{"key":"12943_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2022.05.029","volume":"122","author":"C Ding","year":"2022","unstructured":"Ding C, Hu M, Guo W, Hu W, Li X, Wang S, et al. Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990\u20132019. Int J Infect Dis. 2022;122:46\u201362.","journal-title":"Int J Infect Dis"},{"key":"12943_CR14","volume-title":"Management of Tuberculosis (Fourth Edition)","author":"Clinical Practice Guidelines","year":"2021","unstructured":"Clinical Practice Guidelines. Management of Tuberculosis (Fourth Edition). Malaysia: Ministry of Health Malaysia; 2021."},{"issue":"11","key":"12943_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(11):1269\u201378.","journal-title":"Lancet Infect Dis"},{"key":"12943_CR16","unstructured":"World Health Organization. WHO operational handbook on tuberculosis. Module 1: prevention - tuberculosis preventive treatment. 2nd ed. Geneva: World Health Organization; 2024."},{"issue":"10","key":"12943_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/tmi.13808","volume":"27","author":"KD Sagili","year":"2022","unstructured":"Sagili KD, Muniyandi M, Shringarpure K, Singh K, Kirubakaran R, Rao R, et al. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis. Trop Med Int Health. 2022;27(10):842\u201363.","journal-title":"Trop Med Int Health"},{"issue":"9","key":"12943_CR18","doi-asserted-by":"publisher","first-page":"e1003703","DOI":"10.1371\/journal.pmed.1003703","volume":"18","author":"ML Bastos","year":"2021","unstructured":"Bastos ML, Melnychuk L, Campbell JR, Oxlade O, Menzies D. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis. PLoS Med. 2021;18(9):e1003703.","journal-title":"PLoS Med"},{"key":"12943_CR19","unstructured":"World Bank country and lending groups. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Accessed 7 Jan 2025."},{"key":"12943_CR20","unstructured":"QuantiFERON-TB Gold Plus (QFT-Plus) ELISA package insert, Germany. Qiagen; 2016. https:\/\/www.quantiferon.com\/wp-content\/uploads\/2017\/04\/English_QFTPlus_ELISA_R04_022016.pdf. Assessed 28 Sept 2024."},{"issue":"3","key":"12943_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5588\/ijtld.21.0753","volume":"26","author":"GB Migliori","year":"2022","unstructured":"Migliori GB, Wu SJ, Matteelli A, Zenner D, Goletti D, Ahmedov S, et al. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int J Tuberc Lung Dis. 2022;26(3):190\u2013205.","journal-title":"Int J Tuberc Lung Dis"},{"key":"12943_CR22","volume-title":"Health Care Workers in Ministry of Health Malaysia","author":"Guidelines on Prevention and Management of Tuberculosis for","year":"2012","unstructured":"Guidelines on Prevention and Management of Tuberculosis for. Health Care Workers in Ministry of Health Malaysia. Malaysia: Ministry of Health Malaysia; 2012."},{"key":"12943_CR23","unstructured":"Programmatic management of latent tuberculosis infection. Malaysia: Medical Development Division, Ministry of Health Malaysia; 2019."},{"issue":"2","key":"12943_CR24","first-page":"124","volume":"29","author":"H Wang","year":"2017","unstructured":"Wang H, Peng J, Wang B, Lu X, Zheng JZ, Wang K, et al. Inconsistency Between Univariate and Multiple Logistic Regressions. Shanghai Arch Psychiatry. 2017;29(2):124\u20138.","journal-title":"Shanghai Arch Psychiatry"},{"issue":"3","key":"12943_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bimj.201700067","volume":"60","author":"G Heinze","year":"2018","unstructured":"Heinze G, Wallisch C, Dunkler D. Variable selection - A review and recommendations for the practicing statistician. Biom J. 2018;60(3):431\u201349.","journal-title":"Biom J"},{"key":"12943_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2288-10-7","volume":"10","author":"A Marshall","year":"2010","unstructured":"Marshall A, Altman DG, Royston P, Holder RL. Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Med Res Methodol. 2010;10:7.","journal-title":"BMC Med Res Methodol"},{"key":"12943_CR27","unstructured":"Team RDC. R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2024."},{"key":"12943_CR28","doi-asserted-by":"publisher","first-page":"e19736","DOI":"10.7717\/peerj.19736","volume":"13","author":"AF Mohamed","year":"2025","unstructured":"Mohamed AF, Shafei MN, Wan Mohammad WMZ, Teo R, Min Hui AS. Factors associated with incomplete latent tuberculosis infection preventive treatment in Sabah, Malaysia. PeerJ. 2025;13:e19736.","journal-title":"PeerJ"},{"issue":"7","key":"12943_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/17476348.2021.1862652","volume":"15","author":"C Padmapriyadarsini","year":"2021","unstructured":"Padmapriyadarsini C, Sachdeva KS, Nair D, Ramachandran R. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries. Expert Rev Respir Med. 2021;15(7):899\u2013910.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"12943_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12879-023-08612-2","volume":"23","author":"A Manoharan","year":"2023","unstructured":"Manoharan A, Siti Nur Farhana H, Manimaran K, Khoo EM, Koh WM. Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study. BMC Infect Dis. 2023;23(1):624.","journal-title":"BMC Infect Dis"},{"key":"12943_CR31","doi-asserted-by":"crossref","unstructured":"Spence BC, Bruxvoort K, Munoz-Plaza C, Shaw S, Navarro M, Chen H, et al. Patient-reported barriers to treatment initiation and completion for latent tuberculosis infection among patients within a large integrated health care system in Southern California. J Public Health Manag Pract. 2023;29(3):345\u201352.","DOI":"10.1097\/PHH.0000000000001711"},{"key":"12943_CR32","volume-title":"WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment. Geneva: World Health Organization; 2020."},{"issue":"9","key":"12943_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2016.11046","volume":"316","author":"K Bibbins-Domingo","year":"2016","unstructured":"US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Bauman L, Davidson KW, et al. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316(9):962\u20139.","journal-title":"JAMA"},{"key":"12943_CR34","doi-asserted-by":"publisher","first-page":"927579","DOI":"10.3389\/fmed.2022.927579","volume":"9","author":"J Min","year":"2022","unstructured":"Min J, Kim HW, Stagg HR, Rangaka MX, Lipman M, Abubakar I, et al. The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017\u20132018. Front Med (Lausanne). 2022;9:927579.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"12943_CR35","doi-asserted-by":"publisher","first-page":"ofad219","DOI":"10.1093\/ofid\/ofad219","volume":"10","author":"KJ Bruxvoort","year":"2023","unstructured":"Bruxvoort KJ, Skarbinski J, Fischer H, Li Z, Eaton A, Qian L, et al. Latent Tuberculosis Infection Treatment Practices in Two Large Integrated Health Systems in California, 2009\u20132018. Open Forum Infect Dis. 2023;10(5):ofad219.","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"12943_CR36","doi-asserted-by":"publisher","first-page":"e0289222","DOI":"10.1371\/journal.pone.0289222","volume":"18","author":"PSK Tok","year":"2023","unstructured":"Tok PSK, Wong LP, Liew SM, Razali A, Mahmood MI, Chinnayah T, et al. A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia. PLoS ONE. 2023;18(9):e0289222.","journal-title":"PLoS ONE"},{"key":"12943_CR37","doi-asserted-by":"publisher","first-page":"104687","DOI":"10.1016\/j.ijmedinf.2022.104687","volume":"159","author":"YJ Wong","year":"2022","unstructured":"Wong YJ, Ng KY, Lee SWH. Digital health use in latent tuberculosis infection care: A systematic review. Int J Med Inf. 2022;159:104687.","journal-title":"Int J Med Inf"},{"issue":"1","key":"12943_CR38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1186\/s12913-023-09937-z","volume":"23","author":"SNF H","year":"2023","unstructured":"H SNF, Manoharan A, Koh WM, K M, Khoo EM. Facilitators and barriers to latent tuberculosis infection treatment among primary healthcare workers in Malaysia: a qualitative study. BMC Health Serv Res. 2023;23(1):914.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"12943_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh","year":"2010","unstructured":"Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010;137(2):401\u20139.","journal-title":"Chest"},{"key":"12943_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2458-12-468","volume":"12","author":"ND Goswami","year":"2012","unstructured":"Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain MLM, et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012;12:468.","journal-title":"BMC Public Health"},{"issue":"1","key":"12943_CR41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1186\/s12889-021-10733-9","volume":"21","author":"K Sullivan","year":"2021","unstructured":"Sullivan K, Pease C, Zwerling A, Mallick R, Van Dyk D, Mulpuru S, et al. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country. BMC Public Health. 2021;21(1):964.","journal-title":"BMC Public Health"},{"issue":"12","key":"12943_CR42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S1473-3099(21)00052-9","volume":"21","author":"K Rustage","year":"2021","unstructured":"Rustage K, Lobe J, Hayward SE, Kristensen KL, Margineanu I, Stienstra Y, et al. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(12):1701\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"12943_CR43","doi-asserted-by":"publisher","first-page":"e0231986","DOI":"10.1371\/journal.pone.0231986","volume":"15","author":"PSK Tok","year":"2020","unstructured":"Tok PSK, Liew SM, Wong LP, Razali A, Loganathan T, Chinna K, et al. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study. PLoS ONE. 2020;15(4):e0231986.","journal-title":"PLoS ONE"},{"issue":"4","key":"12943_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF03256289","volume":"12","author":"A Kowada","year":"2008","unstructured":"Kowada A, Takahashi O, Shimbo T, Ohde S, Tokuda Y, Fukui T. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan. Mol Diagn Ther. 2008;12(4):235\u201351.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"12943_CR45","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1186\/s12889-021-11271-0","volume":"21","author":"S Gatechompol","year":"2021","unstructured":"Gatechompol S, Harnpariphan W, Supanan R, Suwanpimolkul G, Sophonphan J, Ubolyam S, et al. Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study. BMC Public Health. 2021;21(1):1206.","journal-title":"BMC Public Health"},{"key":"12943_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jgar.2022.04.025","volume":"29","author":"TR Peng","year":"2022","unstructured":"Peng TR, Chen JH, Chang YH, Shiang JC, Lee MC, Lee CH, et al. Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis. J Glob Antimicrob Resist. 2022;29:378\u201385.","journal-title":"J Glob Antimicrob Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12943-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:43:47Z","timestamp":1774964627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12943-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12943"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12943-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered with the National Medical Research Register (NMRR-23-03453-QQF) and received ethical approval from the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia. As this study involved the secondary analysis of anonymised surveillance data, a waiver of informed consent was granted by MREC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"685"}}